Sara Munro
Family · Allen Park, MINPI 1669046504
Payments from drug & device makers
Across 87 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$582
- AstraZeneca$457
- Neurocrine Biosciences, Inc.$245
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$159
- Novo Nordisk$122
- E.r. Squibb & Sons, L.L.C.$60
- plus $280 from 14 others
What the payments were for
- Food & beverage$1,905100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 32 | $582 |
| AstraZeneca | 18 | $457 |
| Neurocrine Biosciences, Inc. | 7 | $245 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $159 |
| Novo Nordisk | 2 | $122 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| AbbVie | 3 | $57 |
| Bayer | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Viatris Specialty LLC | 1 | $23 |
| Novartis | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Indivior Inc. | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,905 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $49,388 |
| EliquisApixaban | 24 | $23,461 |
| JardianceEmpagliflozin | 16 | $20,091 |
| JanuviaSitagliptin Phosphate | 24 | $18,510 |
| OzempicSemaglutide | 16 | $17,577 |
| MounjaroTirzepatide | 15 | $14,937 |
| TrulicityDulaglutide | 11 | $12,521 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $11,072 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,593 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 102 | $3,610 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,414 |
| Novolog FlexpenInsulin Aspart | 14 | $1,874 |
| Atorvastatin Calcium | 166 | $1,815 |
| Gabapentin | 144 | $1,753 |
| Ventolin HfaAlbuterol Sulfate | 25 | $1,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $582 | $49,38865 claims |
| Lilly USA, LLCMounjaro, Trulicity | $11 | $27,45826 claims |
| Novo NordiskOzempic | $122 | $17,57716 claims |
| AstraZenecaBreztri Aerosphere | $457 | $6,59311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.
Other family in Allen Park
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.